Rita Jain - 05 Jan 2026 Form 4 Insider Report for SAB Biotherapeutics, Inc. (SABS)

Role: Director
Signature: /s/ Grant Levine, attorney-in-fact
Issuer symbol: SABS
Transactions as of: 05 Jan 2026
Net transactions value: $0
Form type: 4
Filing time: 07 Jan 2026, 16:41:02 UTC
Previous filing: 05 Jan 2026
Next filing: 08 Jan 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Jain Rita	Director	777 W 41ST STREET, SUITE 401, MIAMI BEACH	/s/ Grant Levine, attorney-in-fact	07 Jan 2026	0001707797

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SABS	Stock Option (right to buy)	Award	$0	+240,000		$0.000000	240,000	05 Jan 2026	Common Stock	240,000	$3.74	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the inaugural grant to the Reporting Person as a member of the Board of Directors of the Issuer. Shares underlying the option vest in three equal annual installments on January 5, 2027, January 5, 2028 and January 5, 2029.
F2	This award was made pursuant to the Issuer's 2021 Omnibus Equity Incentive Plan, as amended.